Ionis Pharma (IONS) Misses Q1 EPS by 2c

Ionis Pharma (NASDAQ: IONS) reported Q1 EPS of ($0.52), $0.02 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $36.21 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c